STEM education can intimidate many students, but there are ways to ease those fears, says expert Billy Almon. The Latest There’s nothing ‘conservative’ about giving away billions in tax dollars ...

The 2025 Big 12 football season is set to deliver high-stakes battles, fresh rivalries and can’t-miss games from start to finish. Here’s your complete guide to the schedule, including dates, kickoff ...

Bristol-Myers Squibb's has become the first company to bring a cardiac myosin inhibitor through to FDA approval, claiming a green light from the US regulator for mavacamten as a therapy for ...

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...